| Mrs Erin Pacheco, | |
|
640 Warren Ave, East Providence, RI 02914-1405 | |
| (401) 438-2272 | |
| Not Available |
| Full Name | Mrs Erin Pacheco |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 640 Warren Ave, East Providence, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184227621 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RPH04132 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Erin Pacheco, 640 Warren Ave, East Providence, RI 02914-1405 Ph: (401) 438-2272 | Mrs Erin Pacheco, 640 Warren Ave, East Providence, RI 02914-1405 Ph: (401) 438-2272 |
News Archive
A new study showed that Aboriginal smokers residing in remote communities have a significantly lower consumption of cigarettes than the rest of the population. The study was published in the Australian and New Zealand Journal of Public Health on Wednesday.
Omnicell, Inc., a leading provider of system solutions to acute healthcare facilities, today announced a partnership agreement to co-market Sentry Data Systems' Sentinel RCM™ application, which has a sophisticated 340B solution component. Sentry specializes in providing solutions to address a variety of financial challenges found within hospitals and pharmacies while Omnicell's WorkflowRx™ software offers a complete inventory management system for hospital pharmacies.
Investigators from the Slone Epidemiology Center at Boston University School of Medicine have reported that African American women who use oral contraceptives have a greater likelihood of developing breast cancer than nonusers. The study results, recently published on-line in Cancer Epidemiology Biomarkers and Prevention, were based on data from the Black Women's Health Study, a large follow-up study of 59,000 African American women from across the U.S. conducted by investigators at the Slone Epidemiology Center since 1995.
Top-line data from the 270-patient global Phase 2/3 COVID-19 study expected Q1/2021. Top-line data from the 40-patient U.S. Phase 2 study of opaganib in severe COVID-19 expected in the coming days; this non-powered study was designed to evaluate safety and potential identification of preliminary efficacy signals in support of the global Phase 2/3 study of opaganib.
Presented today at the International Osteoporosis Foundation's (IOF) Worldwide Conference of Osteoporosis Patient Societies in Beijing, the 2009 IOF-AMGEN Health Professional Awareness Grants aim to support innovative and cost effective projects by IOF member societies that focus on improving knowledge and raising awareness of osteoporosis among clinicians and allied health professionals.
› Verified 9 days ago
Robin H Carey, RPH, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 950 Warren Ave, East Providence, RI 02914 Phone: 401-606-1004 | |
Cynthia Mary Haggarty, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1925 Pawtucket Ave, East Providence, RI 02914 Phone: 401-431-0476 | |
Gary Steven Kishfy, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Cvs #00269, 583 Taunton Ave, East Providence, RI 02914 Phone: 401-434-2993 Fax: 401-438-3210 | |
Kerri Daw, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1925 Pawtucket Ave, East Providence, RI 02914 Phone: 401-431-0450 | |
Claudia Braga Harris, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 640 Warren Ave, East Providence, RI 02914 Phone: 401-438-2272 | |
Charlie Lee, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 655 Warren Ave, East Providence, RI 02914 Phone: 401-434-5700 |